Massimiliano Ruscica
Massimiliano Ruscica
UniversitÓ degli Studi di Milano; Barts and the London
Verified email at unimi.it
Title
Cited by
Cited by
Year
Dietary iron overload induces visceral adipose tissue insulin resistance
P Dongiovanni, M Ruscica, R Rametta, S Recalcati, L Steffani, S Gatti, ...
The American journal of pathology 182 (6), 2254-2263, 2013
1202013
Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
M Carratelli, L Porcaro, M Ruscica, E De Simone, AA Bertelli, MM Corsi
International journal of clinical pharmacology research 21 (2), 79-84, 2001
1132001
Molecular aspects of adipokine-bone interactions
P Magni, E Dozio, E Galliera, M Ruscica, MM Corsi
Current molecular medicine 10 (6), 522-532, 2010
1092010
Pharmacokinetics of orally administered melatonin in critically ill patients
G Mistraletti, G Sabbatini, M Taverna, MA Figini, M Umbrello, P Magni, ...
Journal of pineal research 48 (2), 142-147, 2010
922010
Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin‐sensitivity, lipid profile andá…
P Magni, A Liuzzi, M Ruscica, E Dozio, S Ferrario, I Bussi, A Minocci, ...
Clinical endocrinology 62 (2), 189-196, 2005
922005
The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
E Dozio, M Ruscica, L Passafaro, G Dogliotti, L Steffani, A Pagani, ...
European journal of pharmacology 641 (1), 29-34, 2010
912010
PCSK9 induces a pro-inflammatory response in macrophages
C Ricci, M Ruscica, M Camera, L Rossetti, C Macchi, A Colciago, I Zanotti, ...
Scientific reports 8 (1), 1-10, 2018
852018
Liver fat accumulation is associated with circulating PCSK9
M Ruscica, N Ferri, C Macchi, M Meroni, C Lanti, C Ricci, M Maggioni, ...
Annals of medicine 48 (5), 384-391, 2016
802016
GC–MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect
F Gelmini, G Beretta, C Anselmi, M Centini, P Magni, M Ruscica, ...
International journal of pharmaceutics 440 (2), 170-178, 2013
792013
Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus
M Ruscica, M Gomaraschi, G Mombelli, C Macchi, R Bosisio, ...
Journal of Clinical Lipidology 8 (1), 61-68, 2014
772014
Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic HepG2 cell line
M Ruscica, C Ricci, C Macchi, P Magni, R Cristofani, J Liu, A Corsini, ...
Journal of Biological Chemistry 291 (7), 3508-3519, 2016
752016
Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells
M Ruscica, E Dozio, S Boghossian, G Bovo, V Martos Riaño, M Motta, ...
Endocrinology 147 (3), 1466-1473, 2006
692006
PPAR agonists and metabolic syndrome: an established role?
M Botta, M Audano, A Sahebkar, CR Sirtori, N Mitro, M Ruscica
International journal of molecular sciences 19 (4), 1197, 2018
672018
Risk identification and possible countermeasures for muscle adverse effects during statin therapy
P Magni, C Macchi, B Morlotti, CR Sirtori, M Ruscica
European journal of internal medicine 26 (2), 82-88, 2015
672015
Feeding behavior in mammals including humans
P Magni, E Dozio, M Ruscica, F Celotti, MA Masini, P Prato, M Broccoli, ...
Annals of the New York Academy of Sciences 1163 (1), 221-232, 2009
642009
A mutation and expression analysis of the oncogene BRAF in pituitary adenomas
I Ewing, S Pedder‐Smith, G Franchi, M Ruscica, M Emery, V Vax, ...
Clinical endocrinology 66 (3), 348-352, 2007
632007
Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer
H Johansson, S Gandini, A Guerrieri-Gonzaga, S Iodice, M Ruscica, ...
Cancer research 68 (22), 9512-9518, 2008
602008
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia
N Ferri, M Ruscica
Endocrine 54 (3), 588-601, 2016
592016
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placement
N Ferri, S Marchian˛, G Tibolla, R Baetta, A Dhyani, M Ruscica, P Uboldi, ...
Atherosclerosis 253, 214-224, 2016
592016
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
JC Fruchart, RD Santos, C Aguilar-Salinas, M Aikawa, K Al Rasadi, ...
Cardiovascular diabetology 18 (1), 1-20, 2019
582019
The system can't perform the operation now. Try again later.
Articles 1–20